Illumina | search
Click here to view Illumina news from 60+ newspapers.
Bookmark or Share- Illumina, Inc. - WikipediaIllumina, Inc. is an American biotechnology company, headquartered in San Diego, California, and it serves more than 155 countries. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.
- Next-Generation Sequencing (NGS) | Explore the technology - IlluminaNext-generation sequencing technology has fundamentally changed the kinds of questions scientists can ask and answer. Innovative sample preparation and data analysis options enable a broad range of applications. For example, NGS allows labs to: Rapidly sequence whole genomes. Deeply sequence target regions.
- Products for Genomics | IlluminaFind microbiology products for next-generation sequencing of bacterial and viral genomes, environmental samples, and more. View array and NGS solutions for immunology research, neuroscience research, and beyond. Array and NGS technologies can broaden cell and molecular biology research beyond the conventional methods.
- Illumina | Sequencing and array solutions to fuel genomic discoveriesTwo Industry Leaders on the Growing Complexity of Genomic Cancer Data. Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.
- Illumina, Inc. - Illumina Announces Preliminary Financial Results for ...Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced unaudited preliminary financial results for the fourth quarter and fiscal year 2023 ahead of its presentation at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024 at 9:00am Pacific Time (12:00pm Eastern Time).
More
